These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema. Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206 [TBL] [Abstract][Full Text] [Related]
30. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes. Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243 [TBL] [Abstract][Full Text] [Related]
31. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367 [TBL] [Abstract][Full Text] [Related]
33. Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease. Yasojima K; McGeer EG; McGeer PL Brain Res; 1999 Jul; 833(2):297-301. PubMed ID: 10375708 [TBL] [Abstract][Full Text] [Related]
34. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Franco RF; de Jonge E; Dekkers PE; Timmerman JJ; Spek CA; van Deventer SJ; van Deursen P; van Kerkhoff L; van Gemen B; ten Cate H; van der Poll T; Reitsma PH Blood; 2000 Jul; 96(2):554-9. PubMed ID: 10887118 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Gerlach M; Keh D; Bezold G; Spielmann S; Kürer I; Peter RU; Falke KJ; Gerlach H Intensive Care Med; 1998 Nov; 24(11):1199-208. PubMed ID: 9876984 [TBL] [Abstract][Full Text] [Related]
36. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579 [TBL] [Abstract][Full Text] [Related]
37. Hereditary and acquired deficiencies of C1 inhibitor. Davis AE Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641 [TBL] [Abstract][Full Text] [Related]
38. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor. Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675 [TBL] [Abstract][Full Text] [Related]
39. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model. Bos IG; van Mierlo GJ; Bleeker WK; Rigter GM; te Velthuis H; Dickneite G; Hack CE Int Immunopharmacol; 2001 Aug; 1(8):1583-95. PubMed ID: 11515821 [TBL] [Abstract][Full Text] [Related]
40. Interferon gamma increases in vitro and in vivo expression of C1 inhibitor. Heda GD; Mardente S; Weiner L; Schmaier AH Blood; 1990 Jun; 75(12):2401-7. PubMed ID: 2112412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]